Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-25-000053
Filing Date
2025-05-13
Accepted
2025-05-13 16:01:18
Documents
54
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20250331.htm   iXBRL 10-Q 683863
2 EX-31.1 exhibit31-1q12025.htm EX-31.1 9089
3 EX-31.2 exhibit31-2q12025.htm EX-31.2 9066
4 EX-32.1 exhibit32-1q12025.htm EX-32.1 4003
5 EX-32.2 exhibit32-2q12025.htm EX-32.2 3838
  Complete submission text file 0001125345-25-000053.txt   4526357

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20250331.xsd EX-101.SCH 30641
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20250331_cal.xml EX-101.CAL 39919
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20250331_def.xml EX-101.DEF 176991
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20250331_lab.xml EX-101.LAB 487406
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20250331_pre.xml EX-101.PRE 329110
56 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20250331_htm.xml XML 516113
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 25939797
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)